Induction with anti-thymocyte globulin in heart transplantation is associated with better long-term survival compared with basiliximab.
(2015) In The Journal of Heart and Lung Transplantation 34(10). p.1283-1291- Abstract
- The use of induction therapy may reduce the risk of acute rejection after heart transplantation. This study assessed the association between basiliximab (BAS) vs anti-thymocyte globulin (ATG) induction and long-term survival after heart transplantation.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/7484916
- author
- Ansari, David LU ; Lund, Lars H ; Stehlik, Josef ; Andersson, Bodil LU ; Höglund, Peter LU ; Edwards, Leah and Nilsson, Johan LU
- organization
- publishing date
- 2015
- type
- Contribution to journal
- publication status
- published
- subject
- in
- The Journal of Heart and Lung Transplantation
- volume
- 34
- issue
- 10
- pages
- 1283 - 1291
- publisher
- Elsevier
- external identifiers
-
- pmid:26087667
- wos:000363095800007
- scopus:84943348562
- pmid:26087667
- ISSN
- 1557-3117
- DOI
- 10.1016/j.healun.2015.04.001
- project
- Pancreatic cancer
- language
- English
- LU publication?
- yes
- id
- 9c878060-541a-4e93-8e99-39b645f5fbe6 (old id 7484916)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/26087667?dopt=Abstract
- date added to LUP
- 2016-04-01 11:03:52
- date last changed
- 2022-02-17 23:47:48
@article{9c878060-541a-4e93-8e99-39b645f5fbe6, abstract = {{The use of induction therapy may reduce the risk of acute rejection after heart transplantation. This study assessed the association between basiliximab (BAS) vs anti-thymocyte globulin (ATG) induction and long-term survival after heart transplantation.}}, author = {{Ansari, David and Lund, Lars H and Stehlik, Josef and Andersson, Bodil and Höglund, Peter and Edwards, Leah and Nilsson, Johan}}, issn = {{1557-3117}}, language = {{eng}}, number = {{10}}, pages = {{1283--1291}}, publisher = {{Elsevier}}, series = {{The Journal of Heart and Lung Transplantation}}, title = {{Induction with anti-thymocyte globulin in heart transplantation is associated with better long-term survival compared with basiliximab.}}, url = {{http://dx.doi.org/10.1016/j.healun.2015.04.001}}, doi = {{10.1016/j.healun.2015.04.001}}, volume = {{34}}, year = {{2015}}, }